EUVIMEDEUVIMED entdecken
Open Access

Immunologic Predictors of Vaccine Responsiveness in Patients With Lymphoma and Chronic Lymphocytic Leukemia

Elise A Chong iD, Kingsley Gideon Kumashie iD, Emeline R Chong, Joseph Fabrizio, Aditi Gupta, Jakub Svoboda, Stefan K Barta, Kristy M Walsh, Ellen B Napier, Rachel K Lundberg, Sunita D Nasta, James N Gerson und 31 weitere

The Journal of Infectious Diseases · 2024

DOI: 10.1093/infdis/jiae106 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2024. Verfasst von Elise A Chong und 42 weiteren Autor:innen. Beteiligte Einrichtung: The Richard Berman Family Innovations Center in CLL and Lymphomas, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylva…. Hauptthemen laut MEDLINE: Leukemia, Lymphocytic, Chronic, B-Cell, COVID-19 Vaccines, COVID-19. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, Steve and Elizabeth Brodie Fund, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with B-cell lymphomas have altered cellular components of vaccine responses due to malignancy and therapy, and the optimal timing of vaccination relative to therapy remains unknown. Severe acute respiratory syndrome coronavirus 2 vaccines created an opportunity for new insights in vaccine timing because patients were challenged with a novel antigen across multiple phases of treatment. We studied serologic messenger RNA vaccine response in retrospective and prospective cohorts with lymphoma and chronic lymphocytic leukemia, paired with clinical and research immune parameters. Reduced serologic response was observed more frequently during active treatment, but nonresponse was also common within observation and posttreatment groups. Total immunoglobulin A and immunoglobulin M correlated with successful vaccine response. In individuals treated with anti-CD19–directed chimeric antigen receptor–modified T cells, nonresponse was associated with reduced B and T follicular helper cells. Predictors of vaccine response varied by disease and therapeutic group, and therefore further studies of immune health during and after cancer therapies are needed to individualize vaccine timing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Lymphocytic, Chronic, B-CellCOVID-19 VaccinesCOVID-19HumansMaleFemaleMiddle AgedAgedRetrospective StudiesProspective StudiesSARS-CoV-2AdultAntibodies, ViralVaccinationImmunoglobulin MLymphomaAged, 80 and over

Stichwörter der Autor:innen

CAR T cellsSARS-CoV-2 vaccinationantibody responselymphomavaccine timing

Substanzen

COVID-19 VaccinesAntibodies, ViralImmunoglobulin M

Autor:innen und Institutionen

  • The Richard Berman Family Innovations Center in CLL and Lymphomas, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania.
  • Division of Hematology/Oncology, Hospital of the University of Pennsylvania.
  • Division of Infectious Diseases, Department of Pediatrics, Children's Hospital of Philadelphia.
  • Immune Health.
  • Department of Microbiology.
  • Center for Cellular Immunotherapies.

ORCID-Profile: Elise A Chong, Kingsley Gideon Kumashie, Scott E Hensley

Förderung

  • NHLBI NIH HHS
  • Steve and Elizabeth Brodie Fund
  • NIH HHS
  • Lymphoma Research Foundation
  • NIAID NIH HHS
  • Postdoctoral Fellowship Grant and Career Development Award
  • NCI NIH HHS
  • Emerson Collective Award

Zitieren

APA

Chong, E. A., Kumashie, K. G., Chong, E. R., Fabrizio, J., Gupta, A., Svoboda, J., Barta, S. K., Walsh, K. M., Napier, E. B., Lundberg, R. K., Nasta, S. D., Gerson, J. N., Landsburg, D. J., Gonzalez, J., Gaano, A., Weirick, M. E., McAllister, C. M., Awofolaju, M., John, G. N., …, & Vella, L. A. (2024). Immunologic Predictors of Vaccine Responsiveness in Patients With Lymphoma and Chronic Lymphocytic Leukemia. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiae106

Vancouver

Chong EA, Kumashie KG, Chong ER, Fabrizio J, Gupta A, Svoboda J, et al. Immunologic Predictors of Vaccine Responsiveness in Patients With Lymphoma and Chronic Lymphocytic Leukemia. The Journal of Infectious Diseases. 2024. doi:10.1093/infdis/jiae106

BibTeX
@article{Chong2024,
  author = {Chong, Elise A and Kumashie, Kingsley Gideon and Chong, Emeline R and Fabrizio, Joseph and Gupta, Aditi and Svoboda, Jakub and Barta, Stefan K and Walsh, Kristy M and Napier, Ellen B and Lundberg, Rachel K and Nasta, Sunita D and Gerson, James N and Landsburg, Daniel J and Gonzalez, Joyce and Gaano, Andrew and Weirick, Madison E and McAllister, Christopher M and Awofolaju, Moses and John, Gavin N and Kammerman, Shane C and Novacek, Josef and Pajarillo, Raymone and Lundgreen, Kendall A and Tanenbaum, Nicole and Gouma, Sigrid and Drapeau, Elizabeth M and Adamski, Sharon and D'Andrea, Kurt and Pattekar, Ajinkya and Hicks, Amanda and Korte, Scott and Sharma, Harsh and Herring, Sarah and Williams, Justine C and Hamilton, Jacob T and Bates, Paul and Hensley, Scott E and Prak, Eline T Luning and Greenplate, Allison R and Wherry, E John and Schuster, Stephen J and Ruella, Marco and Vella, Laura A},
  title = {Immunologic Predictors of Vaccine Responsiveness in Patients With Lymphoma and Chronic Lymphocytic Leukemia},
  journal = {The Journal of Infectious Diseases},
  year = {2024},
  doi = {10.1093/infdis/jiae106}
}
Kostenlos starten →